| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |